Phase I study of the HSP90 inhibitor AUY922 in combination with capecitabine as treatment for patients with advanced solid tumors

被引：0
|
作者：
Bendell, Johanna C.
Hart, Lowell L.
Pant, Shubham
Infante, Jeffrey R.
Jones, Suzanne Fields
Mohyuddin, Adil
Murphy, Patrick
Patton, Jeffrey
Penley, William Charles
Thompson, Dana Shelton
Burris, Howard A.
机构：
[1] PLLC, Sarah Cannon Res Inst Tennessee Oncol, Nashville, TN USA
[2] Florida Canc Specialists SCRI, Ft Myers, FL USA
[3] Stephenson Canc Ctr SCRI, Oklahoma City, OK USA
[4] Sarah Cannon Res Inst & Tennessee Oncol, Nashville, TN USA
[5] Sarah Cannon Res Inst, Nashville, TN USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 04期
关键词：
D O I：
10.1200/jco.2013.31.4_suppl.475
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
475
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Final Results of a Phase 2 Study of the hsp90 Inhibitor Luminespib (AUY922) in NSCLC Patients Harboring EGFR Exon 20 Insertions
    Piotrowska, Z.
    Costa, D.
    Huberman, M.
    Oxnard, G.
    Gainor, J.
    Heist, R.
    Lennes, I.
    Muzikansky, A.
    Shaw, A.
    Azzoli, C.
    Sequist, L.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1776 - S1776
  • [22] PHASE II ACTIVITY OF THE HSP90 INHIBITOR AUY922 IN PATIENTS WITH EGFR-MUTANT ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC
    Barlesi, Fabrice
    Besse, Benjamin
    Chu, Quincy
    Gandhi, Leena
    Griesinger, Frank
    Felip, Enriqueta
    Kang, Jin Hyoung
    Kim, Sang-We
    Rosell, Rafael
    Sequist, Lecia V.
    Soo, Ross
    Wallmark, John
    Avsar, Emin
    Ofosu-Appiah, William
    Pain, Scott
    Akimov, Mikhail
    Garon, Edward B.
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S611 - S612
  • [23] A Phase Ib Trial of the HSP90 Inhibitor AUY922 in Combination with Pemetrexed in Metastatic Non-Squamous, Non-Small Cell Lung Cancer Patients
    Noor, Z.
    Goldman, J. W.
    Lawler, W.
    Melancon, D.
    Telivala, B.
    Braiteh, F.
    Dicarlo, B.
    Kennedy, K.
    Martinez, D.
    Adams, B.
    Wang, X.
    Jones, B.
    Garon, E.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S813 - S814
  • [24] Reactivation of ERK and Akt confers resistance of mutant BRAF colon cancer cells to the HSP90 inhibitor AUY922
    Wang, Chun Yan
    Guo, Su Tang
    Wang, Jia Yu
    Yan, Xu Guang
    Farrelly, Margaret
    Zhang, Yuan Yuan
    Liu, Fen
    Yari, Hamed
    La, Ting
    Lei, Fu Xi
    Jin, Lei
    Zhang, Xu Dong
    Jiang, Chen Chen
    ONCOTARGET, 2016, 7 (31) : 49597 - 49610
  • [25] HSP90 inhibitor AUY922 can reverse Fulvestrant induced feedback reaction in human breast cancer cells
    Bai, Jingchao
    Zhou, Guanglin
    Qiu, Yufan
    Hu, Yunhui
    Liu, Jingjing
    Zhao, Jing
    Zhang, Sheng
    Zhang, Jin
    CANCER SCIENCE, 2017, 108 (06) : 1177 - 1184
  • [26] Preclinical study of HSP-90 inhibitor drug, AUY922 showed good efficacy in treatment of nasopharyngeal cancer
    Yip, Timothy T. C.
    Ngan, Roger K. C.
    Ng, Wai-Tong
    Chan, Lewis T. C.
    Tai, William C. S.
    Cheng, Wai-Wai
    Ma, Victor W. S.
    Lo, Kwok-Wai
    Li, Ya-Ping
    Yang, Michael B. H.
    Wong, Eric C. H.
    Ma, Brigette B. Y.
    Mak, Nai-Ki
    Tsao, George S. W.
    Li-Lung, Maria
    CANCER RESEARCH, 2015, 75
  • [27] A phase I study of Debio 0932, an oral HSP90 inhibitor, in patients with solid tumors
    Isambert, Nicolas
    Hollebecque, Antoine
    Berge, Yann
    van Ingen, Hein
    Brienza, Silvano
    Destaillats, Alice
    Soria, Jean-Charles
    Fumoleau, Pierre
    Delord, Jean-Pierre
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [28] REACTIVATION OF ERK AND AKT CONFERS RESISTANCE OF MUTANT BRAF COLON CANCER CELLS TO THE HSP90 INHIBITOR AUY922
    Wang, Chun Yan
    Guo, Su Tang
    Wang, Jia Yu
    Yan, Xu Guang
    Farrelly, Margaret
    Zhang, Yuan Yuan
    Liu, Fen
    Yari, Hamed
    La, Ting
    Lei, Fu Xi
    Jin, Lei
    Zhang, Xu Dong
    Jiang, Chen Chen
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2016, 12 : 33 - 33
  • [29] PHARMACODYNAMIC EFFECTS OF THE HEAT SHOCK PROTEIN 90 (HSP90) INHIBITOR, AUY922, IN HIGH-RISK, LOCALISED PROSTATE CANCER
    Zhang, A. Y.
    Butler, L. M.
    Stricker, P. D.
    Kench, J. G.
    Tilley, W. D.
    Sebastian, L.
    Stockler, M.
    Horvath, L.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2014, 10 : 46 - 46
  • [30] Anticancer activity of Hsp90 inhibitor AUY922 in nasopharyngeal carcinoma and non-small cell lung cancer cells
    Cho, William C.
    Wong, Chi F.
    CANCER RESEARCH, 2023, 83 (07)
12345